|Work hours||Add information|
|About||Promethera Biosciences is a Belgian pharmaceutical company that develops innovative treatment based on allogeneic adult liver stem cells.|
Promethera Biosciences is a Belgian biotechnology company specialized in the treatment of liver disease using cell therapy. It was founded in 2009 by the Technology Transfer Office of the Université Catholique de Louvain and Professor Etienne Sokal, based on the discovery made by the research and clinical team at UCL. Prof Sokal is a leading expert in hepatology and cell therapy.
Promethera® HepaStem is a cell-based therapy for the treatment of both orphan liver-based metabolic diseases and acquired liver diseases. The originality of the therapy is that a wide variety of diseases can be addressed with the same product.
Promethera Biosciences is now launching its second clinical trial to assess the efficacy of HepaStem in Urea Cycle Disorder patients. The company is currently recruiting patients.